Esperion Therapeutics shares owned by Trium Capital
Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Trium Capital
from 13F filings
Historical chart of Trium Capital investment in Esperion Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Esperion Therapeutics held by Trium Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Esperion Therapeutics by Trium Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $35M | 11M | 3.16 |